Abstract:Background: We sought to explore the potential relationship between serum levels of thyroid hormones with those of androgen and metabolic parameters in women with polycystic ovary syndrome (PCOS). Methods: Data from 1059 Chinese women with PCOS and 1015 healthy women was retrospectively collected. This data including fasting glucose and insulin, thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4), total triiodothyronine (TT3), total thyroxine (TT4), anti-thyroperoxidase antibody (ANTI-TPO), anti-thyroglobulin (ATG), dehydroepiandrosterone sulfate (DHEAS), total testosterone (TTE), follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), prolactin (PRL), progesterone (PGN), triglyceride (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL) and low-density lipoprotein cholesterol (LDL). Thyroid-related indicators were compared between PCOS and non-PCOS patients enrolled in this study. Independent variables of PCOS were compared among subgroups in accordance with the classification of TSH, homeostatic model assessment of insulin resistance (HOMA-IR), and TTE levels. To further explore the association between thyroid hormones levels and correlated metabolic parameters in PCOS, multiple regression analyses were conducted. Results: Our study found that PCOS patients had significantly higher serum TSH, FT3, TT3 and TT4 levels than non-PCOS patients. PCOS patients with TSH >= 2.5 mIU/L had significantly higher TG, fasting insulin, HOMA-IR and homeostatic model assessment of beta-cell function (HOMA-B), however, these patients also displayed significantly lower DHEAS, HDL, and quantitative insulin sensitivity check index (QUICKI) when compared to patients with TSH levels <2.5 mIU/L. PCOS patients with HOMA-IR levels >= 2.5 mIU/L demonstrated significantly higher FT3 and TSH, but lower TT3 when compared to women with HOMA-IR levels <2.5 mIU/L. Four groups divided by TTE displayed significant differences in FT3 in PCOS patients. Multiple linear regression analysis showed that TSH was significantly negatively associated with DHEAS and QUICKI. Conclusions: TSH levels are closely correlated to the metabolic and endocrine characteristics of PCOS, especially dyslipidemia and insulin resistance.

Tyrosine Phosphorylation and Protein Expression of Insulin Receptor Substrate-2 in the Adipose Tissue from Patients with Polycystic Ovary Syndrome

[Autophosphorylation of Erythrocyte Insulin Receptors in Patients with Polycystic Ovary Syndrome].

Expression of insulin receptor substrate-1 in endometrium of patients with polycystic ovary syndrome combined with insulin resistance

Relationship Between Insulin Resistance and Adiponectin Expression in a Rat Model of Polycystic Ovary Syndrome.

Association of Serum Thyroid Hormone Levels with Androgen and Metabolic Parameters in Chinese Women with Polycystic Ovary Syndrome: A Retrospective Cross-Sectional Study

Upregulation of adiponectin receptor 1 and 2 mRNA and protein in adipose tissue and adipocytes in insulin-resistant women with polycystic ovary syndrome

Clinical study of insulin resistance in women with polycystic ovary syndrome

Gly~(972) Arg polymorphism and expression of insulin receptor substrate 1 of endometria in patients with polycystic ovary syndrome with insulin resistance

Distribution of adiponectin multimeric forms in Chinese women with polycystic ovary syndrome and their relation to insulin resistance.

UHPLC/Q-TOFMS-based Plasma Metabolomics of Polycystic Ovary Syndrome Patients with and Without Insulin Resistance

Association of Abdominal Obesity, Insulin Resistance, and Oxidative Stress in Adipose Tissue in Women with Polycystic Ovary Syndrome.

The occurrence of insulin resistance and metabolic syndrome in polycystic ovary syndrome

Insulin resistance in polycystic ovary syndrome associated with obesity

[A Case-Control Study of Correlation Between Serum Adiponectin Levels and Polycystic Ovary Syndrome].

Insulin resistance and high molecular weight adiponectin in obese and non-obese patients with Polycystic Ovarian Syndrome (PCOS)

Correlation between single nucleotide polymorphism of insulin receptor gene with polycystic ovary syndrome]

Expression of insulin receptor substrate 1 and its serine 307 site phosphorylation in rat skeletal muscle with polycystic ovary syndrome

Comprehensive Assessment the Expression of Core Elements Related to IGFIR/PI3K Pathway in Granulosa Cells of Women with Polycystic Ovary Syndrome

Endocrine and metabolizable characters of polycystic ovary syndrome patients

[Correlations Between Adipocytokines and Insulin Resistance in Women with Polycystic Ovary Syndrome].

ODP642 Differences in hormonal profiles and vitamin D status depending on the insulin sensitivity status in women with polycystic ovary syndrome (PCOS).